Stock Events

Stock Events

Mayne Pharma Group Limited 

$2.12
14
+$0.25+13.1%Friday 15:39

Statistics

Day High
1.87
Day Low
1.87
52W High
3.9
52W Low
1.4
Volume
350
Avg. Volume
1,046
Mkt Cap
171.84M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Dividends

0%Dividend Yield
Jan 2023
$0.39
Mar 2011
$0.21
Nov 2010
$0.39
10Y Growth
N/A
5Y Growth
N/A
3Y Growth
N/A
1Y Growth
N/A

Earnings

Aug 26Expected
Q4 2023
Q1 2024
Q2 2024
Q4 2024
Q2 2025
Q4 2025
Q2 2026
-0.91
-0.61
-0.3
0.01
Expected EPS
-0.3284422894854087
Actual EPS
-0.3496321146134997

Financials

6.78%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
254MRevenue
17.22MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MAYNF. It's not an investment recommendation.
Westpac Banking
7
WBC.AU
Woodside Energy Group
6
WDS.AU
ANZ Group
6
ANZ.AU
National Australia Bank Limited
6
NAB.AU

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Teva- Pharmaceutical Industries
TEVA
Mkt Cap49.72B
Teva Pharmaceutical Industries Ltd. is a global leader in generic medicines, directly competing with Mayne Pharma in the generics market.
Perrigo Company
PRGO
Mkt Cap2.2B
Perrigo Company plc specializes in over-the-counter healthcare products, competing with Mayne Pharma in the consumer health market.
Johnson & Johnson
JNJ
Mkt Cap664.95B
Johnson & Johnson operates in the pharmaceutical, medical devices, and consumer health sectors, competing with Mayne Pharma particularly in the pharmaceutical and consumer health products sectors.
Pfizer
PFE
Mkt Cap167.52B
Pfizer Inc. is a global pharmaceutical corporation that competes with Mayne Pharma in the development and distribution of both generic and specialty pharmaceuticals.
Abbvie
ABBV
Mkt Cap514.92B
AbbVie Inc. is a research-based biopharmaceutical company that competes with Mayne Pharma in the development and marketing of pharmaceutical products, particularly in areas like dermatology.
GSK
GSK
Mkt Cap100.88B
GlaxoSmithKline plc is a global healthcare company that competes with Mayne Pharma in the pharmaceutical and healthcare sectors, including areas such as respiratory diseases, vaccines, and consumer healthcare products.

About

Mayne Pharma Group Ltd. operates as a specialized pharmaceutical enterprise, dedicated to the global production and distribution of both proprietary (branded) and unbranded (generic) medicinal products. Its extensive market reach spans Australia, New Zealand, North America (the United States and Canada), Europe, and Asia. The company's business activities are organized across four distinct divisions: Metrics Contract Services, International, Branded Products, and Portfolio Products. Mayne Pharma offers innovative oral drug delivery technologies and provides comprehensive contract services, including pharmaceutical development, manufacturing, and analytical support to external clients. Furthermore, the firm specializes in the distribution of pharmaceutical products tailored for key therapeutic areas such as dermatology, women's health, and infectious diseases. Incorporated in 2005, and headquartered in Salisbury South, Australia, the company was formerly known as Halcygen Pharmaceuticals Limited before rebranding to Mayne Pharma Group Limited in November 2010.
Show More
CEO
Aaron Gray
Employees
363
Country
Australia
ISIN
AU000000MYX0
WKN
000A1C821

Listings

STU
DE
HG6.STU
AU
AU
MYX.AU
OTC Link
US
MAYNF
F
DE
HG6.F

0 Comments

Share your thoughts

FAQs

What is Mayne Pharma Group Limited stock price today?▼
The current price of MAYNF is $2.12 USD — it has increased by +13.1% in the past 24 hours. Watch Mayne Pharma Group Limited stock price performance more closely on the chart.
What is Mayne Pharma Group Limited stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Mayne Pharma Group Limited stocks are traded under the ticker MAYNF.
Is Mayne Pharma Group Limited stock price growing?▼
MAYNF stock has risen by +14.32% compared to the previous week, the month change is a +13.1% rise, over the last year Mayne Pharma Group Limited has showed a -26.31% decrease.
What is Mayne Pharma Group Limited market cap?▼
Today Mayne Pharma Group Limited has the market capitalization of 171.84M
When is the next Mayne Pharma Group Limited earnings date?▼
Mayne Pharma Group Limited is going to release the next earnings report on February 24, 2027.
What were Mayne Pharma Group Limited earnings last quarter?▼
MAYNF earnings for the last quarter are -0.25 USD per share, whereas the estimation was -0.24 USD resulting in a -6.45% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Mayne Pharma Group Limited revenue for the last year?▼
Mayne Pharma Group Limited revenue for the last year amounts to 254M USD.
What is Mayne Pharma Group Limited net income for the last year?▼
MAYNF net income for the last year is 17.22M USD.
Does Mayne Pharma Group Limited pay dividends?▼
Yes, MAYNF dividends are paid quarterly. The last dividend per share was 0.39 . As of today, Dividend Yield (FWD)% is 0%.
How many employees does Mayne Pharma Group Limited have?▼
As of November 9, 2026, the company has 363 employees.
In which sector is Mayne Pharma Group Limited located?▼
Mayne Pharma Group Limited operates in the Health & Wellness sector.
When did Mayne Pharma Group Limited complete a stock split?▼
The last stock split for Mayne Pharma Group Limited was on January 18, 2023 with a ratio of 1:20.
Where is Mayne Pharma Group Limited headquartered?▼
Mayne Pharma Group Limited is headquartered in Salisbury South, Australia.